Godavari Drugs Ltd share price logo

Godavari Drugs Ltd Share Price (530317)

Check the latest share price of Godavari Drugs Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.

₹94.950.32%

as on 04:01PM, 13 Jun 2025

BSE

bell
The current prices are delayed by 15 mins, login to check live prices.

Godavari Drugs Ltd Stock Performance

Get live Godavari Drugs Ltd share price, day's high and low, historical returns, and market stats.

  • Day's Low

    Day's High

    ₹93
    Day's Price Range
    ₹95.8
  • 52 Week's Low

    52 Week's High

    ₹79
    52-Week Price Range
    ₹155
1 Month Return+ 1.03 %
3 Month Return+ 0.19 %
1 Year Return-5.57 %
3 Year Return+ 42.57 %
5 Year Return+ 461.83 %
Previous Close₹94.65
Open₹93.00
Volume2,041.00
Upper Circuit₹113.58
Lower Circuit₹75.72

Godavari Drugs Ltd Fundamentals & Key Indicators

Check Godavari Drugs Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

₹71.50 Cr

Return on Equity (ROE)

15.33

PE Ratio (TTM)

0

Return on capital employed (ROCE)

14.14

Beta (LTM)

0.77

P/B Ratio

1.8

Dividend Yield

0

PEG Ratio

0

Quarterly Earnings Growth YOY

-66.54

EPS (TTM)

0

Sector

Pharmaceuticals

Book Value

0

Technical Analysis

How to invest in Godavari Drugs Ltd?

Investing in Godavari Drugs Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Godavari Drugs Ltd or 530317 on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

For example: You can buy 10 shares of Godavari Drugs Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Godavari Drugs Ltd with just a few clicks!

Godavari Drugs Ltd Stock's Interest Amongst Investors

145%

Period Jun 15, 2025 to May 16, 2025. Change in 30 Days vs previous period

Search interest for Godavari Drugs Ltd Stock has increased by 145% in the last 30 days, reflecting an upward trend in search activity.

Godavari Drugs Ltd Financial Results

Get the annual and quarterly financial summary of Godavari Drugs Ltd, including revenue, profit, loss and more.

Value in ₹ crore
DetailsQ4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25
Revenue

(in ₹ Cr)

39 (0%)32 (17%)26 (19%)30 (13%)26 (14%)
Net Income

(in ₹ Cr)

3 (0%)2 (39%)1 (33%)1 (29%)1 (16%)
Net Profit Margin6.88% (0%)5.06% (26%)4.18% (17%)2.61% (38%)3.49% (34%)
Value in ₹ crore
DetailsFY21FY22FY23FY24
Total Assets

(in ₹ Cr)

91 (0%)101 (11%)121 (20%)135 (11%)
Total Liabilities

(in ₹ Cr)

67 (0%)72 (8%)88 (23%)96 (9%)
Value in ₹ crore
DetailsFY20FY21FY22FY23FY24
Operating Cash Flow

(in ₹ Cr)

6 (0%)1 (79%)11 (744%)13 (18%)18 (39%)

Godavari Drugs Ltd Earnings and Dividends

View detailed summary of the earnings and dividend history of Godavari Drugs Ltd.

  • Godavari Drugs Ltd Earnings Results

    Godavari Drugs Ltd’s net profit fell -66.54% since last year same period to ₹0.89Cr in the Q4 2024-2025. On a quarterly growth basis, Godavari Drugs Ltd has generated 15.58% jump in its net profits since last 3-months.

    Read More about Earnings Results

Godavari Drugs Ltd Shareholding Pattern

View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Godavari Drugs Ltd.

InvestorsHoldings %Quarterly Trend3M change
Promoter Holdings
52.63%
0.00
Foreign Institutions
0%
0.00
Mutual Funds
0%
0.00
Retail Investors
46.87%
0.00
Others
0.5%
0.00

Godavari Drugs Ltd vs Peers

Compare market cap, revenue, PE, and other key metrics of Godavari Drugs Ltd with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA71.5092.37%0.805156
NA6.245.19%5.69NANA
NA81.5858.65%0.51140
NA1,949.0625.81%0.5158630
NA69.916.88%0.78245

Godavari Drugs Ltd News & Key Events

Latest news and events in one place to help you make informed investing decisions in Godavari Drugs Ltd.

  • Godavari Drugs Reports Significant Decline in Financials - 10 Jun, 2025

    Godavari Drugs reported a 34% decline in net sales to Rs 25.50 crore for March 2025, with net profit down 66.45% to Rs 0.89 crore. EPS decreased to Rs 1.19. The stock has seen a -24.05% return over the last 6 months.

Insights on Godavari Drugs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, Godavari Drugs stock has moved up by 0.2%

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 46.87% of holdings in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 88.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 50.9%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 52.63% of holdings in Mar 2025 quarter

About Godavari Drugs Ltd

Godavari Drugs (GD) is a drug manufacturing company with the main product being Sulphamethoxazole (SMX). In order to increase their SMX capacity from 540 tons per annum (tpa) to 720 tpa, the company is undertaking backward integration into the manufacture of 450 tpa drug intermediates Sulphamethoxide (SMO) and 750 tpa Diethyl Oxalate (DEO) as well as diversifying into 144 tpa Trimetroprim (TMP). Combining SMX and TMP provides treatment for a broader range of infections. GD also introduced Pyrazyamide (180 tpa) in 2000 and is now planning to increase its capacity, along with a new intermediate Cislactum for the production of anti anginal drug Diltiazem. All actions to increase value-addition are set to give GD profitable export demand.

Revenue: ₹25.50Cr as on March 2025 (Q4 FY25)
Net Profit: ₹0.89Cr as on March 2025 (Q4 FY25)
Chairperson Name: Ghanshyam Jaju
OrganisationGodavari Drugs Ltd
IndustryPharmaceuticals
CEOGhanshyam Jaju
E-voting on sharesClick here to vote

FAQs

What is Godavari Drugs Ltd share price today?

Godavari Drugs Ltd share price today stands at ₹94.95, Open: ₹93, Previous Close: ₹94.65, High: ₹95.8, Low: ₹93, 52 Week High: ₹155, 52 Week Low: ₹79.

What is today's traded volume of Godavari Drugs Ltd?

Today's traded volume of Godavari Drugs Ltd is 2,041.00. Which means that 2,041.00 shares of Godavari Drugs Ltd were bought and sold on the stock market during today's trading session.

What is Godavari Drugs Ltd's market cap today?

Today's market capitalisation of Godavari Drugs Ltd is ₹71.50 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.

What is the 52 week high and 52 week low range of Godavari Drugs Ltd?

Godavari Drugs Ltd’s 52 week high is ₹155 and 52 week low is ₹79. The current share price of Godavari Drugs Ltd is ₹94.95, which is -38.74% down from its 52 week high and 20.19% up from its 52 week low.